Skip to main content
Figure 5 | Trials

Figure 5

From: Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D)

Figure 5

Cumulative registration of potential DILT1D participants. Individual publicity events were observed to impact different recruitment sources with the University of Cambridge and Wellcome Trust increasing internet registration, while the Diabetes UK post increased the clinics and register sources.

Back to article page

Trials

ISSN: 1745-6215